{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:58:18Z","timestamp":1788350298480,"version":"build-2803163510"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"33","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"UCL\/UCLH Biomedicine NIHR"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1093\/eurheartj\/ehaf1067","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:56:57Z","timestamp":1766235417000},"page":"4618-4620","source":"Crossref","is-referenced-by-count":1,"title":["Risk stratification for RYR2-mediated catecholaminergic polymorphic ventricular tachycardia: time to broaden the lens"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9831-6817","authenticated-orcid":false,"given":"William J","family":"Young","sequence":"first","affiliation":[{"name":"Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London , Charterhouse Square, London EC1M 6BQ ,","place":["UK"]},{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital , West Smithfield, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9055-9267","authenticated-orcid":false,"given":"Pier D","family":"Lambiase","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, St Bartholomew\u2019s Hospital , West Smithfield, London ,","place":["UK"]},{"name":"Institute of Cardiovascular Sciences, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026090119563201700_ehaf1067-B1","doi-asserted-by":"publisher","first-page":"e12512","DOI":"10.1111\/anec.12512","article-title":"Catecholaminergic polymorphic ventricular tachycardia, an update","volume":"23","author":"P\u00e9rez-Riera","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026090119563201700_ehaf1067-B2","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026090119563201700_ehaf1067-B3","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"2026090119563201700_ehaf1067-B4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/europace\/eur277","article-title":"Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments","volume":"14","author":"van der Werf","year":"2012","journal-title":"Europace"},{"key":"2026090119563201700_ehaf1067-B5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"key":"2026090119563201700_ehaf1067-B6","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1093\/eurheartj\/ehaf965","article-title":"Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification","volume":"47","author":"Lieve","year":"2026","journal-title":"Eur Heart J"},{"key":"2026090119563201700_ehaf1067-B7","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.hrthm.2021.07.061","article-title":"Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Kallas","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026090119563201700_ehaf1067-B8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026090119563201700_ehaf1067-B9","doi-asserted-by":"publisher","first-page":"euae294","DOI":"10.1093\/europace\/euae294","article-title":"Prognostic relevance of baseline exercise stress test in RYR2-related CPVT","volume":"27","author":"Kukavica","year":"2025","journal-title":"Europace"},{"key":"2026090119563201700_ehaf1067-B10","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/europace\/euv357","article-title":"Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"T\u00fcl\u00fcmen","year":"2016","journal-title":"Europace"},{"key":"2026090119563201700_ehaf1067-B11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/jce.14043","article-title":"Chronotropic incompetence as a risk predictor in children and young adults with catecholaminergic polymorphic ventricular tachycardia","volume":"30","author":"Franciosi","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026090119563201700_ehaf1067-B12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.hrthm.2018.08.025","article-title":"Linking the heart and the brain: neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"16","author":"Lieve","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026090119563201700_ehaf1067-B13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1253\/circj.CJ-16-0250","article-title":"Catecholaminergic polymorphic ventricular tachycardia (CPVT) associated with ryanodine receptor (RyR2) gene mutations\u2014long-term prognosis after initiation of medical treatment","volume":"80","author":"Kawata","year":"2016","journal-title":"Circ J"},{"key":"2026090119563201700_ehaf1067-B14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/s41467-018-04148-1","article-title":"Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system","volume":"9","author":"Ram\u00edrez","year":"2018","journal-title":"Nat Commun"},{"key":"2026090119563201700_ehaf1067-B15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jacc.2007.09.069","article-title":"Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome","volume":"51","author":"Schwartz","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/33\/4618\/66326192\/ehaf1067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/33\/4618\/66326192\/ehaf1067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:56:39Z","timestamp":1788306999000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/33\/4618\/8418280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":15,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf1067","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,1]]},"published":{"date-parts":[[2026,1,9]]}}}